BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1394190)

  • 1. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
    O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
    Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
    O'Boyle KP; Coatsworth S; Anthony G; Ramirez M; Greenwald E; Kaleya R; Steinberg JJ; Dutcher JP; Wiernik PH
    Cancer Immun; 2006 Mar; 6():5. PubMed ID: 16524255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
    MacLean GD; Reddish MA; Koganty RR; Longenecker BM
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
    O'Boyle KP; Wright K
    Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
    Zhang S; Walberg LA; Ogata S; Itzkowitz SH; Koganty RR; Reddish M; Gandhi SS; Longenecker BM; Lloyd KO; Livingston PO
    Cancer Res; 1995 Aug; 55(15):3364-8. PubMed ID: 7614472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.
    Adluri S; Helling F; Ogata S; Zhang S; Itzkowitz SH; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1995 Sep; 41(3):185-92. PubMed ID: 7553688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
    Singhal A; Fohn M; Hakomori S
    Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
    O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
    Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
    Ogata S; Maimonis PJ; Itzkowitz SH
    Cancer Res; 1992 Sep; 52(17):4741-6. PubMed ID: 1511439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.
    Gilewski TA; Ragupathi G; Dickler M; Powell S; Bhuta S; Panageas K; Koganty RR; Chin-Eng J; Hudis C; Norton L; Houghton AN; Livingston PO
    Clin Cancer Res; 2007 May; 13(10):2977-85. PubMed ID: 17504999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer.
    Coomber DW; Hawkins NJ; Dalley D; Ward RL
    Neoplasma; 1998; 45(1):12-6. PubMed ID: 9604995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
    Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
    Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.
    MacLean GD; Reddish M; Koganty RR; Wong T; Gandhi S; Smolenski M; Samuel J; Nabholtz JM; Longenecker BM
    Cancer Immunol Immunother; 1993; 36(4):215-22. PubMed ID: 8439984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
    J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTn.
    Kircheis R; Vondru P; Nechansky A; Ohler R; Loibner H; Himmler G; Mudde GC
    Bioconjug Chem; 2005; 16(6):1519-28. PubMed ID: 16287250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An O-acetylated sialyl-Tn is involved in ovarian cancer-associated antigenicity.
    Toba S; Tenno M; Kurosaka A
    Biochem Biophys Res Commun; 2000 May; 271(2):281-6. PubMed ID: 10799288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.